{
  "id": 4601,
  "text": "</td><td>Conditional recommendation, low-certainty evidence </td><td>33.WHO suggests that women living with HIV who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AlS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VIA or co-testing, and, if negative, are retested again at 12 months and, if negative again, move to the recommended regular screening interval.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: </td><td>Conditional recommendation, low-certainty evidence </td><td>33.WHO suggests that women living with HIV who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AlS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VIA or co-testing, and, if negative, are retested aga\n\n<question>: ",
  "ChatGPT_response_0": "世界卫生组织建议，在接受治疗后的经过组织病理学确认为CIN2/3或平滑肌腺癌原位癌（AIS）的HIV感染妇女，或因阳性筛查而接受治疗的妇女，在12个月后应进行HPV DNA检测，而不是细胞学检查或视诊醋酸溶液染色或共同检测。如果HPV DNA检测为阴性，应在12个月后再次进行检测，如果再次为阴性，则可以按照建议的常规筛查间隔进行检查。",
  "query": "在什么情况下，世界卫生组织建议艾滋病毒感染的妇女进行HPV DNA检测而不是细胞学检查或视诊醋酸溶液染色或共同检测？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在什么情况下，世界卫生组织建议艾滋病毒感染的妇女进行HPV DNA检测而不是细胞学检查或视诊醋酸溶液染色或共同检测？\n\n<reference text>: </td><td>Conditional recommendation, low-certainty evidence </td><td>33.WHO suggests that women living with HIV who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AlS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VIA or co-testing, and, if negative, are retested again at 12 months and, if negative again, move to the recommended regular screening interval.\n\n<reply>: ",
  "response": "世界卫生组织建议，在接受治疗后的经过组织病理学确认为CIN2/3或平滑肌腺癌原位癌（AIS）的HIV感染妇女，或因阳性筛查而接受治疗的妇女，在12个月后应进行HPV DNA检测，而不是细胞学检查或视诊醋酸溶液染色或共同检测。如果HPV DNA检测为阴性，应在12个月后再次进行检测，如果再次为阴性，则可以按照建议的常规筛查间隔进行检查。"
}